The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients
Open accessAbstract
Type 1A diabetes (T1D) is an autoimmune disease characterized by leukocyte infiltration of the pancreatic islets of Langerhans. A major impediment to advances in understanding, preventing, and curing T1D has been the inability to "see" the disease initiate, progress, or regress, especially during the occult phase. Here, we report the development of a noninvasive method to visualize T1D at the target organ level in patients with active insulitis. Specifically, we visualized islet inflammation, manifest by microvascular changes and monocyte/macrophage recruitment and activation, using magnetic resonance imaging of magnetic nanoparticles (MNPs). As a proof of principle for this approach, imaging of infused ferumoxtran-10 nanoparticles permitted effective visualization of the pancreas and distinction of recent-onset diabetes patients from nondiabetic controls. The observation that MNPs accumulate in the pancreas of T1D patients opens the door to exploiting this noninvasive imaging method to follow T1D progression and monitoring the ability of immunomodulatory agents to clear insulitis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This allows for early discrimination between diabetic and healthy individuals [178].”
From Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications (2019) · cites this paper as [178]
Citations
Cites
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022749 · Cited by 1,971
Self-citationFoulis, A. K., Liddle, C. N., Farquharson, M. A., Richmond, J. A., & Weir, R. S. (1986) · Diabetologia · doi:10.1007/bf00452061 · Cited by 469
Itoh, N., Hanafusa, T., Miyazaki, A., Miyagawa, J.-I., Yamagata, K., Yamamoto, K., Waguri, M., Imagawa, A., Tamura, S., & Inada, M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116835 · Cited by 347
Hänninen, A. L. M., Jalkanen, S., Salmi, M., Toikkanen, S., Nikolakaros, G., & Simell, O. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116067 · Cited by 242
Müller, K. H., Skepper, J. N., Pósfai, M., Trivedi, R. A., Howarth, S. P. S., Corot, C., Lancelot, E., Thompson, P. W., Brown, A. P., & Gillard, J. H. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.12.003 · Cited by 237
Foulis, A. K., & Stewart, J. A. (1984) · Diabetologia · doi:10.1007/bf00262221 · Cited by 233
Imaging inflammation of the pancreatic islets in type 1 diabetes
Denis, M. C., Mahmood, U., Benoist, C. O., Mathis, D. J., & Weissleder, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404307101 · Cited by 176
Self-citationL�hr, M., & Kl�ppel, G. (1987) · Diabetologia · doi:10.1007/bf00275740 · Cited by 171
A comprehensive guide to antibody and T‐cell responses in type 1 diabetes
Lieberman, S. M., & DiLorenzo, T. P. (2003) · Tissue Antigens · doi:10.1034/j.1399-0039.2003.00152.x · Cited by 170
The pancreas as a single organ: the influence of the endocrine upon the exocrine part of the gland.
Henderson, J. R., Daniel, P. M., & Fraser, P. A. (1981) · Gut · doi:10.1136/gut.22.2.158 · Cited by 169
Flagged first, then by citations
Research works printed but not linked: 2
- Papaccio, 1993, Histol Histopathol., 8, 751
- Signore, 1996, Clin Exp Rheumatol., 14 suppl 15, S41
Cited by
Sorted by citations
Items 101–200 of 211
A Deeper Look into Type 1 Diabetes – Imaging Immune Responses during Onset of Disease
Christoffersson, G., & von Herrath, M. G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00313 · Cited by 23
Molecular imaging of diabetes and diabetic complications: Beyond pancreatic β-cell targeting
Yang, J., Zhang, L. J., Wang, F., Hong, T., & Liu, Z. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.11.007 · Cited by 25
Longitudinal Assessment of Pancreas Volume by MRI Predicts Progression to Stage 3 Type 1 Diabetes
Virostko, J. M., Wright, J. J., Williams, J. M., Hilmes, M. A., Triolo, T. M., BRONCUCIA, H. C., Du, L., Kang, H., Nallaparaju, S., Valencia, L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-1681 · Cited by 23
Tooley, J., & Herold, K. C. (2014) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000076 · Cited by 23
Silva, I., Teixeira, A., Oliveira, J. C., Almeida, R., & Vasconcelos, C. (2017) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-150044 · Cited by 21
Repeatability and Reproducibility of Pancreas Volume Measurements Using MRI
Williams, J. M., Hilmes, M. A., Archer, B. T., Dulaney, A., Du, L., Kang, H., Russell, W. E., Powers, A. C., Moore, D. J., & Virostko, J. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-61759-9 · Cited by 20
Álvarez, K., & Rojas, M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19861 · Cited by 22
Pellico, J., Llop, J., Fernández‐Barahona, I., Bhavesh, R., Ruı́z-Cabello, J., & Herranz, F. (2017) · Contrast Media & Molecular Imaging · doi:10.1155/2017/1549580 · Cited by 20
Cells and Iron Oxide Nanoparticles on the Move
Sosnovik, D. E., & Nahrendorf, M. (2012) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.112.978932 · Cited by 20
Diabetes as a Pancreatic Microvascular Disease—A Pericytic Perspective
Gonçalves, L. M., Barboza, C. D. A., & Almaça, J. (2024) · Journal of Histochemistry & Cytochemistry · doi:10.1369/00221554241236535 · Cited by 19
Beumer, W., Effraimidis, G., Drexhage, R. C., Wiersinga, W. M., & Drexhage, H. A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4122 · Cited by 19
Berclaz, C., Schmidt-Christensen, A., Szlag, D., Extermann, J., Hansen, L., Bouwens, A., Villiger, M., Goulley, J., Schuit, F. C., Grapin‐Botton, A., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3819-x · Cited by 19
Molecular Imaging of Autoimmune Diseases and Inflammation
Sargsyan, S. A., & Thurman, J. M. (2012) · Molecular Imaging · doi:10.2310/7290.2011.00045 · Cited by 19
Development of MR quantified pancreatic fat deposition as a cancer risk biomarker
Coe, P. O., Williams, S. R., Morris, D. M., Parkin, E., Harvie, M., Renehan, A. G., & O'Reilly, D. A. (2018) · Pancreatology · doi:10.1016/j.pan.2018.04.001 · Cited by 20
New Evidence of Exocrine Pancreatopathy in Pre-symptomatic and Symptomatic Type 1 Diabetes
Vecchio, F., Messina, G., Giovenzana, A., & Petrelli, A. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1223-5 · Cited by 18
Application of Polymeric Nano-Materials in Management of Inflammatory Bowel Disease
Minakshi, P., Kumar, R., Ghosh, M., Brar, B., Barnela, M., & Lakhani, P. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200320113322 · Cited by 17
Protti, A., Dong, X., Andía, M. E., Yu, B., Dokukina, K., Chaubey, S., Phinikaridou, A., Vizcay‐Barrena, G., Taupitz, M., Botnar, R. M., et al. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24191 · Cited by 17
Nanosized Contrast Agents to Noninvasively Detect Kidney Inflammation by Magnetic Resonance Imaging
Thurman, J. M., & Serkova, N. J. (2013) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2013.06.001 · Cited by 16
Dybala, M. P., Gebien, L. R., Reyna, M. E., Yu, Y. A., & Hara, M. (2020) · Diabetes · doi:10.2337/db20-0810 · Cited by 16
Juang, J., Shen, C., Wang, J., Kuo, C.-H., Chien, Y.-W., Kuo, H.-Y., Chen, F., Chen, M. H., Yen, T., & Tsai, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062626 · Cited by 16
Which factors determine exocrine pancreatic dysfunction in diabetes mellitus?
Altay, M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i22.2699 · Cited by 19
Wu, Y., Yang, B., Cai, H., Qin, W., Zhang, B., Zhai, C., & Jiang, B. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s52058 · Cited by 15
Experiments by nature: lessons on type 1 diabetes
Battaglia, M. (2013) · Tissue Antigens · doi:10.1111/tan.12280 · Cited by 14
Diabetes mellitus in childhood: an emerging condition in the 21st century
Manna, T. D., Setian, N., Savoldelli, R. D., Guedes, D. R., Kuperman, H., Filho, H. C. M., Steinmetz, L., Cominato, L., Dichtchekenian, V., & Damiani, D. (2016) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.62.06.594 · Cited by 17
Haupt‐Jorgensen, M., Buschard, K., Hansen, A. K., Josefsen, K. E., & Antvorskov, J. C. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2802 · Cited by 13
Berclaz, C., Szlag, D., Nguyen, D., Extermann, J., Bouwens, A., Marchand, P. J., Nilsson, J., Schmidt-Christensen, A., Holmberg, D., Grapin‐Botton, A., et al. (2016) · Biomedical Optics Express · doi:10.1364/boe.7.004569 · Cited by 13
Ali, Z., Chandrasekera, P. C., & Pippin, J. J. (2018) · Alternatives to Laboratory Animals · doi:10.1177/026119291804600101 · Cited by 13
Aetiology of type 1 diabetes: Physiological growth in children affects disease progression
Skog, O., & Korsgren, O. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13144 · Cited by 14
Detecting insulitis in type 1 diabetes with ultrasound phase-change contrast agents
Ramirez, D. G., Ciccaglione, M., Upadhyay, A., Pham, V. T., Borden, M. A., & Benninger, R. K. P. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2022523118 · Cited by 13
Lachaud, C. C., Cobo‐Vuilleumier, N., Fuente-Martín, E., Diaz, I., Andreu, E., Cahuana, G. M., Tejedo, J. R., Hmadcha, A., Gauthier, B. R., & Soria, B. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1089817 · Cited by 12
Type 1 diabetes: immune pathology and novel therapeutic approaches
Ling, E. M., Lemos, J. R. N., Hirani, K., & von Herrath, M. (2024) · Diabetology International · doi:10.1007/s13340-024-00748-z · Cited by 13
Nanoparticulate Systems for Controlling Monocyte/Macrophage Behavior
Pentecost, A., Lurier, E. B., & Spiller, K. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-20726-1_14 · Cited by 12
Nanotechnology in Kidney and Islet Transplantation: An Ongoing, Promising Field
Wang, W., Teng, Y., Xue, J.-J., Cai, H.-K., Pan, Y.-B., Ye, X.-N., Mao, X., & Li, S.-W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.846032 · Cited by 12
Shen, S., Ding, W., Ahmed, S. U., Hu, R., Opalacz, A., Roth, S., You, Z., Wotjkiewicz, G. R., Lim, G., Chen, L. L., et al. (2017) · Pain Medicine · doi:10.1093/pm/pnx267 · Cited by 12
Nanotechnology's application in Type 1 diabetes
Pan, W. H., Zheng, X., Chen, G., Su, L., Luo, S., Wang, W., Ye, S., Weng, J., & Min, Y. (2020) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1645 · Cited by 12
Imaging evaluation of the pancreas in diabetic patients
Zeng, N., Wang, Y., Cheng, Y., Huang, Z., & Song, B. (2021) · Abdominal Radiology · doi:10.1007/s00261-021-03340-0 · Cited by 11
Histological and transcriptional characterization of the pancreatic acinar tissue in type 1 diabetes
Granlund, L., Hedin, A., Wahlhütter, M., Seiron, P., Korsgren, O., Skog, O., & Lundberg, M. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-002076 · Cited by 11
Jain, K. K. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6966-1_4 · Cited by 10
Saini, S., Korf, H., Liang, S., Verbeke, R., Manshian, B. B., Raemdonck, K., Lentacker, I., Gysemans, C. A., Smedt, S. C. D., & Himmelreich, U. (2019) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-018-0720-x · Cited by 10
Exocrine pancreas function is impaired in adult relatives of patients with type 1 diabetes
Giovenzana, A., Vecchio, F., Cugnata, F., Nonis, A., Mandelli, A., Stabilini, A., Mazzi, B. A., Pellegrin, M. D., Laurenzi, A., Bonfanti, R., et al. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01819-2 · Cited by 10
Paredes-Juarez, G. A., de Vos, P., & Bulte, J. W. M. (2017) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2017.1302305 · Cited by 10
Theranostic MRI: the future for Type 1 diabetes management?
Wang, P., & Moore, A. V. (2014) · Imaging in Medicine · doi:10.2217/iim.13.67 · Cited by 9
Imaging NF‐κB activity in a murine model of early stage diabetes
Taghian, T., Metelev, V., Zhang, S., & Bogdanov, A. A., Jr. (2019) · The FASEB Journal · doi:10.1096/fj.201801147r · Cited by 9
Understanding secretion, ageing and death in β cells
Weir, G. C. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.236 · Cited by 8
Atkinson, M. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00032-0 · Cited by 8
Targeting immunosuppressor cells with nanoparticles in autoimmunity: How far have we come to?
Ahmad, S., Al-Hatamleh, M. A. I., & Mohamud, R. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104412 · Cited by 10
Jovicic, N. U., Petrović, I., Pejnovic, N. N., Ljujić, B., Kovačević, M. M., Pavlovic, S. M., Jeftic, I. D., Djukić, A., Srejovic, I. M., Jakovljevic, V. L., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.714683 · Cited by 8
Mathavan, S., Chen‐Tan, N., Arfuso, F., & Al‐Salami, H. (2018) · AAPS PharmSciTech · doi:10.1208/s12249-018-1127-8 · Cited by 7
Immune biomarkers in immunotherapeutic trials for type 1 diabetes: Cui prodest?
Čulina, S., & Mallone, R. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.05.005 · Cited by 7
Nanotechnology: Antidiabetics, Antioxidant and Anti-inflammatory
Samrat, K., Murthy, T. P. K., Divyashri, G., Krishna, R. H., & Chandraprabha, M. N. (2023) · Springer eBooks · doi:10.1007/978-981-99-1635-1_8 · Cited by 6
Saini, S., Vanherwegen, A.-S., Liang, S., Verbeke, R., Korf, H., Lentacker, I., Smedt, S. C. D., Gysemans, C. A., & Himmelreich, U. (2022) · Molecular Imaging and Biology · doi:10.1007/s11307-021-01701-1 · Cited by 6
Nutritional markers in patients with diabetes and pancreatic exocrine failure
Alexandre‐Heymann, L., Lemoine, A. Y., Nakib, S., Kapel, N., Ledoux, S., & Larger, É. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01294-w · Cited by 6
The Evolution of Iron Oxide Nanoparticles as MRI Contrast Agents
O’Shea, A., Parakh, A., Lahoud, R. M., Hedgire, S., & Harisinghani, M. G. (2020) · MRS Advances · doi:10.1557/adv.2020.311 · Cited by 6
Self-citationPre-Labeling of Immune Cells in Normal Bone Marrow and Spleen for Subsequent Cell Tracking by MRI
Siegers, G. M., Krishnamoorthy, S., González-Lara, L. E., McFadden, C. D., Chen, Y., & Foster, P. J. (2016) · Tomography · doi:10.18383/j.tom.2016.00103 · Cited by 5
Mukhopadhyay, A., & Prosenjit, M. (2018) · Journal of Clinical and Molecular Endocrinology · doi:10.21767/2572-5432.100047 · Cited by 5
Heat‐Induced Radiolabeling of Nanoparticles for Monocyte Tracking by PET
Normandin, M. D., Yuan, H., Wilks, M. Q., Chen, H. H., Kinsella, J. M., Cho, H., Guehl, N. J., Absi‐Halabi, N., Hosseini, S. M., Fakhri, G. E., et al. (2015) · Angewandte Chemie · doi:10.1002/ange.201505525 · Cited by 4
Imaging the Pancreatic Beta Cell
Ahlgren, U., & Kostromi, E. (2011) · InTech eBooks · doi:10.5772/22739 · Cited by 4
Regulation of Normal and Adaptive Pancreatic Growth
Williams, J. A. (2020) · doi:10.3998/panc.2020.05 · Cited by 4
Patangia, U., Bhatta, K., Vig, H., Priya, S., Wal, A., Tyagi, L. K., & Wal, P. (2024) · Current Nanomedicine · doi:10.2174/0124681873265152231229042106 · Cited by 3
Epidemiology and Pathogenesis of Type 1 Diabetes
Stene, L. C., & Lernmark, Å. (2023) · Springer eBooks · doi:10.1007/978-3-031-20999-4_2 · Cited by 3
Immunological biomarkers: Catalysts for translational advances in autoimmune diabetes
Ahmed, S. T., Akirav, E. M., Bradshaw, E. M., Buckner, J. H., McKinney, E. F., Quintana, F. J., Waldron-Lynch, F., & Nepom, G. T. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12063 · Cited by 3
Alterations of the pancreas in type 1 diabetes – from prior to diagnosis to long-standing disease
Missima, N. G., Hill, H., Aioanei, C. S., Liss, P., & Espes, D. (2025) · Endocrine · doi:10.1007/s12020-025-04338-0 · Cited by 4
B cell depletion in autoimmune diabetes: insights from murine models
Chamberlain, J. L., Attridge, K., Wang, C. J., Ryan, G. A., & Walker, L. S. K. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.561320 · Cited by 3
Cho, H. R., Lee, Y., Doble, P., Bishop, D., Hare, D. J., Kim, Y., Kim, K. G., Jung, H. S., Park, K. S., Choi, S. H., et al. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i19.5831 · Cited by 3
IN DEBATE: THE PRIMARY CAUSE OF TYPE 1 DIABETES
Ionescu-Tirgoviste, C., Guja, C., Gagniuc, P. A., Davila, C., & Paulescu, N. (2014) · Cited by 2
Autoimmunity in motion: Mechanisms of immune regulation and destruction revealed by in vivo imaging*
Jacobelli, J., Buser, A. E., Heiden, D. L., & Friedman, R. S. (2021) · Immunological Reviews · doi:10.1111/imr.13043 · Cited by 3
Testing a new platform to screen disease-modifying therapy in type 1 diabetes
Lord, S. M., Bahnson, H. T., Greenbaum, C. J., Liljenquist, D. R., Virostko, J. M., & Speake, C. (2023) · PLoS ONE · doi:10.1371/journal.pone.0293268 · Cited by 2
Solving the plot: early events are the key to diabetes intervention
Chervonsky, A. V. (2012) · Nature Immunology · doi:10.1038/ni.2259 · Cited by 2
Imaging of Insulitis in NOD Mice with IL-2-Gd-DTPA and 1.5 T MRI
Kalliokoski, T., Svedström, E., Saunavaara, J. P., Roivainen, A., Kankaanpää, M., Oivanen, H., Nuutila, P., & Simell, O. (2011) · Advances in Molecular Imaging · doi:10.4236/ami.2011.13006 · Cited by 2
Piya, A., Michels, A. W., & Fellow, P. E. (2012) · US Endocrinology · doi:10.17925/use.2012.08.01.12 · Cited by 2
Zhang, L., & Thurber, G. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-61401-4_8 · Cited by 2
Fukase, A., Fukui, T., Mori, Y., Nagaike, H., Goto, S., Hayashi, T., Yamamoto, T., Ohara, M., Sasamori, H., & Hirano, T. (2019) · Diabetes and Endocrinology · doi:10.24983/scitemed.de.2019.00101 · Cited by 2
Pathogenesis of Type 1 Diabetes
Pugliese, A. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_7 · Cited by 2
Cutting-edge nanotechnology in diabetes care: metamorphosing diagnostics and treatment strategies
Sarkhel, S., Shuvo, S. M., Sarkar, T., GHOSH, A., Kapat, P., & Biswas, R. (2026) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-026-00941-8 · Cited by 2
Speculation on Prevention of Type 1 Diabetes
Insel, R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-4051-2_31 · Cited by 1
Patel, S. K. (2015) · Cited by 1
Magnetic Resonance Imaging Agents
Wang, C., Rodrı́guez, E., & Chen, J. W. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816386-3.00037-5 · Cited by 1
Functionalized magnetic nanosystems in nanomedicine
Renushe, A. P., Devi, K. K., Singh, G., Sathua, K. B., Navik, U., Banothu, A. K., Bharani, K. K., & Khurana, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19012-4.00014-x · Cited by 1
Nanoimaging in Infection and Inflammation
Shaikh, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-7292-6_18 · Cited by 1
Pathogenesis of Type 1 Diabetes
Pugliese, A. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_7-1 · Cited by 1
Regulation of Normal and Adaptive Pancreatic Growth
Williams, J. A. (2017) · doi:10.3998/panc.2017.02 · Cited by 1
Immunotherapies for Type 1 Diabetes
Gürr, W. (2013) · InTech eBooks · doi:10.5772/54717
Approaches for Imaging Pancreatic Islets: Recent Advances and Future Prospects
Montet, X., Lamprianou, S., Vinet, L., Meda, P., & Fort, A. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_39
Pancreatic beta-cell failure in the pathogenesis of type 1 diabetes
Sharland, A. F. (2012) · The Sydney eScholarship Repository (The University of Sydney)
Immunohistochemical study of the pancreas of patients with long termed diabetes mellitus type 1
Proshchina, A. E., Krivova, Y. S., Barabanov, V. M., & Saveliev, S. (2013) · Frontiers in Immunology · doi:10.3389/conf.fimmu.2013.02.00978
Studies of Enterovirus Infection and Induction of Innate Immunity in Human Pancreatic Cells
Anagandula, M. (2016) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Harms, R. Z., Lorenzo-Arteaga, K. M., Corley, K. P., Cabrera, M. S., Sarvetnick, E., & Fiorina, P. (2015)
Clinical Experience with Nanoparticles in Imaging
Sutphin, P. D., & Harisinghani, M. G. (2014) · Frontiers in nanobiomedical research · doi:10.1142/9789814520652_0050
Self-citationNanoprobes to Monitor Cell Processes in the Pancreas
Billotey, C., Aspord, C., Gazeau, F., Perriat, P., Tillement, O., Thivolet, C. H., & Janier, M. F. (2012) · Science Publishers eBooks · doi:10.1201/b11775-12
Approaches for Imaging Pancreatic Islets: Recent Advances and Future Prospects
Montet, X., Lamprianou, S., Vinet, L., Meda, P., & Fort, A. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_39-2
Evaluation of Crohn's disease activity: an integrated imaging approach
Maccioni, F. (2013) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Ionescu-Tirgoviste, C., Gagniuc, P. A., Stoica, R. A., & Guja, C. (2015)
Jhala, G. (2016) · Minerva Access (University of Melbourne)
Molecular Imaging Agent Design for Quantifying Beta Cell Mass in Type 1 Diabetes
Zhang, L. (2017) · Deep Blue (University of Michigan)
Study of Insulin Attached onto Magnetic Nanoparticles
Bhatti, M. A. (2018)
Joosten, L., Boss, M., Jansen, T. J. P., Brom, M., Buitinga, M., Aarntzen, E. H. J. G., Eriksson, O., Johansson, L., de Galan, B. E., & Gotthardt, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816386-3.00041-7
Tegehall, A., Ingvast, S., Åsa, M., Skog, O., & Korsgren, O. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.10.472088
(2011) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32834dd969
Metadata
- Authors
- Gaglia, J. L., Guimaraes, A. R., Harisinghani, M., Turvey, S. E., Jackson, R., Benoist, C., Mathis, D., & Weissleder, R.
- Affiliations
- Harvard University (US)
- Broad Institute (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2011-01-04
- Volume
- 121
- Issue
- 1
- Pages
- 442-445
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3007157
- OpenAlex
- W2067753785
- Cited by
- 209
- References
- 21
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 6 · 2023: 11 · 2022: 5 · 2021: 16 · 2020: 9 · 2019: 13 · 2018: 14 · 2017: 15 · 2016: 19 · 2015: 26 · 2014: 17 · 2013: 20 · 2012: 22
- FWCI
- 9.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- Cancer Research Institute
- Pfizer
- RSNA Research and Education Foundation
- Radiological Society of North America
- Harvard University
- Harvard Catalyst (UL1-RR025758, RR025758)
- Covis Pharma
- National Institutes of Health (5u54ca119349-05, P50-CA86355, U54-CA119349, CA119349, CA86355)
- U.S. Public Health Service (P01-A1-054904)
- National Heart, Lung, and Blood Institute (U01HL080731)
- National Cancer Institute (P50-CA-86355, U24CA092782, P50CA086355, U54 CA-119349)
- National Center for Research Resources (UL1RR025758)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Physical Sciences › Engineering › Biomedical Engineering › Characterization and Applications of Magnetic Nanoparticles
- Keywords
- type 1A diabetes, insulitis, pancreatic islet inflammation, non-invasive imaging, magnetic nanoparticles, ferumoxtran-10, magnetic resonance imaging, monocyte/macrophage recruitment, microvascular changes, autoimmune disease
- MeSH terms
- Adolescent, Adult, Dextrans, Diabetes Mellitus, Type 1, Female, Humans, Inflammation, Islets of Langerhans, Macrophages, Magnetic Resonance Imaging, Male, Microcirculation, Monocytes, Case-Control Studies, Young Adult, Magnetite Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review